APO RESEARCH · REPORT
Anti-Infective Ophthalmic
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
Product & engineering
Understand the product.
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
Selected research
Industry Research
Anti-Infective Ophthalmic Industry Research Report 2026
Market perspective
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
Report Scope
Read the full market overview
This report quantifies the global Anti-Infective Ophthalmic market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-Infective Ophthalmic Market by Company
Novartis
Allergan
Valeant Pharmaceuticals
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Anti-Infective Ophthalmic Segment by Type
Antibacterial
Antiviral
Antifungal
Anti-Parasitic
Others
Anti-Infective Ophthalmic Segment by Application
Hospital
Clinic
Household
Others
Anti-Infective Ophthalmic Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infective Ophthalmic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Infective Ophthalmic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infective Ophthalmic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-Infective Ophthalmic manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-Infective Ophthalmic by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-Infective Ophthalmic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antibacterial
- Antiviral
- Antifungal
- Anti-Parasitic
- Others
Applications
- Hospital
- Clinic
- Household
- Others
Companies covered
- Novartis
- Allergan
- Valeant Pharmaceuticals
- Santen Pharmaceutical
- Lupin Pharmaceuticals
- Apotex
- Akorn
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anti-Infective Ophthalmic Market Size (2021-2032)
- 2.2.2 Global Anti-Infective Ophthalmic Sales (2021-2032)
- 2.2.3 Global Anti-Infective Ophthalmic Market Average Price (2021-2032)
- 2.3 Anti-Infective Ophthalmic by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antibacterial
- 2.3.3 Antiviral
- 2.3.4 Antifungal
- 2.3.5 Anti-Parasitic
- 2.3.6 Others
- 2.4 Anti-Infective Ophthalmic by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Household
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anti-Infective Ophthalmic Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anti-Infective Ophthalmic Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Anti-Infective Ophthalmic Revenue of Manufacturers (2021-2026)
- 3.4 Global Anti-Infective Ophthalmic Average Price by Manufacturers (2021-2026)
- 3.5 Global Anti-Infective Ophthalmic Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anti-Infective Ophthalmic, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anti-Infective Ophthalmic, Product Type & Application
- 3.8 Global Manufacturers of Anti-Infective Ophthalmic, Established Date
- 3.9 Global Anti-Infective Ophthalmic Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Anti-Infective Ophthalmic Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Allergan
- 4.2.1 Allergan Company Information
- 4.2.2 Allergan Business Overview
- 4.2.3 Allergan Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Allergan Anti-Infective Ophthalmic Product Portfolio
- 4.2.5 Allergan Recent Developments
- 4.3 Valeant Pharmaceuticals
- 4.3.1 Valeant Pharmaceuticals Company Information
- 4.3.2 Valeant Pharmaceuticals Business Overview
- 4.3.3 Valeant Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Valeant Pharmaceuticals Anti-Infective Ophthalmic Product Portfolio
- 4.3.5 Valeant Pharmaceuticals Recent Developments
- 4.4 Santen Pharmaceutical
- 4.4.1 Santen Pharmaceutical Company Information
- 4.4.2 Santen Pharmaceutical Business Overview
- 4.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Santen Pharmaceutical Anti-Infective Ophthalmic Product Portfolio
- 4.4.5 Santen Pharmaceutical Recent Developments
- 4.5 Lupin Pharmaceuticals
- 4.5.1 Lupin Pharmaceuticals Company Information
- 4.5.2 Lupin Pharmaceuticals Business Overview
- 4.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Portfolio
- 4.5.5 Lupin Pharmaceuticals Recent Developments
- 4.6 Apotex
- 4.6.1 Apotex Company Information
- 4.6.2 Apotex Business Overview
- 4.6.3 Apotex Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Apotex Anti-Infective Ophthalmic Product Portfolio
- 4.6.5 Apotex Recent Developments
- 4.7 Akorn
- 4.7.1 Akorn Company Information
- 4.7.2 Akorn Business Overview
- 4.7.3 Akorn Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Akorn Anti-Infective Ophthalmic Product Portfolio
- 4.7.5 Akorn Recent Developments
5 Global Anti-Infective Ophthalmic Market Scenario by Region
- 5.1 Global Anti-Infective Ophthalmic Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anti-Infective Ophthalmic Sales by Region: 2021-2032
- 5.2.1 Global Anti-Infective Ophthalmic Sales by Region: 2021-2026
- 5.2.2 Global Anti-Infective Ophthalmic Sales by Region: 2027-2032
- 5.3 Global Anti-Infective Ophthalmic Revenue by Region: 2021-2032
- 5.3.1 Global Anti-Infective Ophthalmic Revenue by Region: 2021-2026
- 5.3.2 Global Anti-Infective Ophthalmic Revenue by Region: 2027-2032
- 5.4 North America Anti-Infective Ophthalmic Market Facts & Figures by Country
- 5.4.1 North America Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anti-Infective Ophthalmic Sales by Country (2021-2032)
- 5.4.3 North America Anti-Infective Ophthalmic Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Anti-Infective Ophthalmic Market Facts & Figures by Country
- 5.5.1 Europe Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anti-Infective Ophthalmic Sales by Country (2021-2032)
- 5.5.3 Europe Anti-Infective Ophthalmic Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Anti-Infective Ophthalmic Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anti-Infective Ophthalmic Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anti-Infective Ophthalmic Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anti-Infective Ophthalmic Market Facts & Figures by Country
- 5.7.1 South America Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anti-Infective Ophthalmic Sales by Country (2021-2032)
- 5.7.3 South America Anti-Infective Ophthalmic Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Anti-Infective Ophthalmic Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anti-Infective Ophthalmic Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anti-Infective Ophthalmic Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anti-Infective Ophthalmic Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Anti-Infective Ophthalmic Sales by Type (2021-2032)
- 6.1.1 Global Anti-Infective Ophthalmic Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Anti-Infective Ophthalmic Sales Market Share by Type (2021-2032)
- 6.2 Global Anti-Infective Ophthalmic Revenue by Type (2021-2032)
- 6.2.1 Global Anti-Infective Ophthalmic Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anti-Infective Ophthalmic Revenue Market Share by Type (2021-2032)
- 6.3 Global Anti-Infective Ophthalmic Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anti-Infective Ophthalmic Sales by Application (2021-2032)
- 7.1.1 Global Anti-Infective Ophthalmic Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Anti-Infective Ophthalmic Sales Market Share by Application (2021-2032)
- 7.2 Global Anti-Infective Ophthalmic Revenue by Application (2021-2032)
- 7.2.1 Global Anti-Infective Ophthalmic Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anti-Infective Ophthalmic Revenue Market Share by Application (2021-2032)
- 7.3 Global Anti-Infective Ophthalmic Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anti-Infective Ophthalmic Value Chain Analysis
- 8.1.1 Anti-Infective Ophthalmic Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anti-Infective Ophthalmic Production Mode & Process
- 8.2 Anti-Infective Ophthalmic Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anti-Infective Ophthalmic Distributors
- 8.2.3 Anti-Infective Ophthalmic Customers
9 Global Anti-Infective Ophthalmic Analyzing Market Dynamics
- 9.1 Anti-Infective Ophthalmic Industry Trends
- 9.2 Anti-Infective Ophthalmic Industry Drivers
- 9.3 Anti-Infective Ophthalmic Industry Opportunities and Challenges
- 9.4 Anti-Infective Ophthalmic Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst